Cargando…

Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects

INTRODUCTION: Parkinson’s disease (PD), the second most common neurodegenerative disease after Alzheimer’s disease, affects 1% of the population after the age of 60. Motor symptoms are the most common features that may be associated with non-motor symptoms including psychotic symptoms. OBJECTIVES: F...

Descripción completa

Detalles Bibliográficos
Autores principales: Nzamba Nzamba, D., Benallel, K., Kaddaf, A., Gartoum, M., Kadiri, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567882/
http://dx.doi.org/10.1192/j.eurpsy.2022.1194
_version_ 1784809510490079232
author Nzamba Nzamba, D.
Benallel, K.
Kaddaf, A.
Gartoum, M.
Kadiri, M.
author_facet Nzamba Nzamba, D.
Benallel, K.
Kaddaf, A.
Gartoum, M.
Kadiri, M.
author_sort Nzamba Nzamba, D.
collection PubMed
description INTRODUCTION: Parkinson’s disease (PD), the second most common neurodegenerative disease after Alzheimer’s disease, affects 1% of the population after the age of 60. Motor symptoms are the most common features that may be associated with non-motor symptoms including psychotic symptoms. OBJECTIVES: Faire le point sur les modalités de prise en charge des symptômes psychotiques au cours de la maladie de Parkinson METHODS: Nous décrivons 3 cas de développement de symptômes psychotiques, survenus chez des patients atteints de la maladie de Parkinson, et faisons le point sur la prise en charge des manifestations symptomatiques psychiatriques dans la maladie de Parkinson, par une brève revue de la littérature. RESULTS: Case 1: 42-year-old man, with 5 years’ history of PD, presented with auditory hallucinations comorbid with paranoid personality disorder, which occurred 12 months following antiparkinsonian drugs use. Case 2: 58-year-old man, with 17 years’ history of PD, presented jealousy delusions and behavioral disorders, which occurred 12 years following antiparkinsonian drugs use. Case 3: 76-year-old man, with 36 years’ history of PD, presented visual hallucinations, subjective sensation of a presence and jealousy delusion, which occurred 26 years following antiparkinsonian drugs use. CONCLUSIONS: Les symptômes psychotiques de la maladie de Parkinson sont fréquents. La prise en charge consiste à traiter les symptômes psychotiques sans aggraver les symptômes moteurs liés à l’hypo-dopaminergie. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9567882
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95678822022-10-17 Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects Nzamba Nzamba, D. Benallel, K. Kaddaf, A. Gartoum, M. Kadiri, M. Eur Psychiatry Abstract INTRODUCTION: Parkinson’s disease (PD), the second most common neurodegenerative disease after Alzheimer’s disease, affects 1% of the population after the age of 60. Motor symptoms are the most common features that may be associated with non-motor symptoms including psychotic symptoms. OBJECTIVES: Faire le point sur les modalités de prise en charge des symptômes psychotiques au cours de la maladie de Parkinson METHODS: Nous décrivons 3 cas de développement de symptômes psychotiques, survenus chez des patients atteints de la maladie de Parkinson, et faisons le point sur la prise en charge des manifestations symptomatiques psychiatriques dans la maladie de Parkinson, par une brève revue de la littérature. RESULTS: Case 1: 42-year-old man, with 5 years’ history of PD, presented with auditory hallucinations comorbid with paranoid personality disorder, which occurred 12 months following antiparkinsonian drugs use. Case 2: 58-year-old man, with 17 years’ history of PD, presented jealousy delusions and behavioral disorders, which occurred 12 years following antiparkinsonian drugs use. Case 3: 76-year-old man, with 36 years’ history of PD, presented visual hallucinations, subjective sensation of a presence and jealousy delusion, which occurred 26 years following antiparkinsonian drugs use. CONCLUSIONS: Les symptômes psychotiques de la maladie de Parkinson sont fréquents. La prise en charge consiste à traiter les symptômes psychotiques sans aggraver les symptômes moteurs liés à l’hypo-dopaminergie. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9567882/ http://dx.doi.org/10.1192/j.eurpsy.2022.1194 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Nzamba Nzamba, D.
Benallel, K.
Kaddaf, A.
Gartoum, M.
Kadiri, M.
Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects
title Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects
title_full Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects
title_fullStr Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects
title_full_unstemmed Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects
title_short Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects
title_sort psychotic symptoms and parkinson’s disease: clinical and therapeutic aspects
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567882/
http://dx.doi.org/10.1192/j.eurpsy.2022.1194
work_keys_str_mv AT nzambanzambad psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects
AT benallelk psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects
AT kaddafa psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects
AT gartoumm psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects
AT kadirim psychoticsymptomsandparkinsonsdiseaseclinicalandtherapeuticaspects